P030: Baseline IgM amount can identify patients with adverse outcome despite a PET-2 adapted treatment in classical Hodgkin Lymphoma: results from a real-life single-center study i

Detalles Bibliográficos
Autores principales: Romano, Alessandra, Cerchione, Claudio, Santuccio, Gabriella, Le Moli, Marialudovica, Chiarenza, Annalisa, Figuera, Amalia, Motta, Giovanna, Caruso, L., Lanza, Sofia, Petronaci, A., Poidomani, S., Ippolito, Massimo, Di Raimondo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Genomics, Biology & Microenvironment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642049/
http://dx.doi.org/10.1097/01.HS9.0000890688.01421.7a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642049/
http://dx.doi.org/10.1097/01.HS9.0000890688.01421.7a

Ejemplares similares